The discovery could help people with muscle-wasting disorders and even astronauts on extended space voyages by putting space travelers into a hibernation-like state.
Public health officials expect antiviral pills to become an increasingly common treatment for COVID-19 that will reduce the severity of the disease in at-risk patients and decrease the burden of the pandemic.
If the world already had a pan-coronavirus vaccine in March 2020, it could have served as a mitigation tool until vaccines specific to SARS-CoV-2 could be developed.
A gene that cured a man of HIV a decade ago has been successfully added to developing monkey embryos in an effort to study more potential treatments for the disease.
A study shows that the mutant virus is more easily transmitted and grows better within hosts, likely aiding its dominance. The mutation, researchers say, should not interfere with the effectiveness of vaccines against the virus.
Neither of the new viruses is known to infect people, but the findings reinforce the important work scientists are undertaking to study the effects of a changing environment on human and animal diseases.
Researchers believe the same approach can be applied to several other respiratory pathogens, including the novel coronavirus that causes COVID-19.
The trials center around an “antibody cocktail” called REGN-COV2, which was created by the New York-based pharmaceutical company Regeneron.
The animals are useful to researchers trying to understand SARS-CoV-2 and in the evaluation of vaccines, treatments and drugs against the disease it causes.
Researchers advise that people with symptoms avoid contact with cats, and cat owners should keep their pets indoors to limit contact with other people and animals.